Endovascular Treatment of Acute Stroke.
James A GilesAnanth K VellimanaOpeolu M AdeoyePublished in: Current neurology and neuroscience reports (2022)
In the last four years, clinical trial evidence has expanded the time window for successful endovascular treatment to 24 h. Current research is aimed at expanding patient selection to mild strokes, large ischemic cores and occlusions of smaller, more distal blood vessels. Further, we have developed understanding of how to manage blood pressure after thrombectomy and even had promising results for a neuroprotective agent in these patients. Thrombectomy has transformed the treatment of ischemic stroke due to large-vessel occlusion. Recent research has focused on expanding patient candidacy for endovascular treatment and improving medical management to support better neurologic outcomes.
Keyphrases
- endovascular treatment
- clinical trial
- blood pressure
- end stage renal disease
- case report
- acute ischemic stroke
- newly diagnosed
- ejection fraction
- chronic kidney disease
- healthcare
- cerebral ischemia
- atrial fibrillation
- minimally invasive
- heart rate
- randomized controlled trial
- type diabetes
- hypertensive patients
- phase ii
- double blind
- combination therapy
- brain injury
- blood glucose